Intech Investment Management LLC Has $1.62 Million Position in Encompass Health Co. (NYSE:EHC)

Intech Investment Management LLC increased its position in shares of Encompass Health Co. (NYSE:EHC) by 31.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 17,514 shares of the company’s stock after purchasing an additional 4,143 shares during the quarter. Intech Investment Management LLC’s holdings in Encompass Health were worth $1,617,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. CIBC Asset Management Inc grew its holdings in shares of Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after purchasing an additional 100 shares in the last quarter. Miracle Mile Advisors LLC increased its holdings in Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after buying an additional 112 shares during the period. US Bancorp DE raised its stake in shares of Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after buying an additional 121 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after acquiring an additional 125 shares during the period. Finally, CBIZ Investment Advisory Services LLC boosted its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after acquiring an additional 127 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 2.10% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $97.05 on Friday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 52 week low of $76.11 and a 52 week high of $104.55. The company’s 50 day moving average price is $97.98 and its two-hundred day moving average price is $97.10. The company has a market capitalization of $9.77 billion, a P/E ratio of 21.76, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Analysts Set New Price Targets

EHC has been the subject of several recent research reports. Barclays increased their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Finally, StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.